Galena Biopharma to Present at the 2012 BIO International Convention

        Print
| Source: Galena Biopharma

LAKE OSWEGO, Ore., June 18, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2012 BIO International Convention. The presentation will take place on Wednesday, June 20, 2012 at 9:30 a.m. EDT at the Boston Convention and Exhibition Center in Boston, MA.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647

Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109

or
Remy Bernarda
IR Sense, LLC
+1 (503) 400-6995